Eleni Chantzoura
Director of Discovery,
MiNK Therapeutics
Mani Mudaliar
Target Analyst Director,
Exscientia
Miguel Gaspar
Director,
Astrazeneca
Sari Pesonen
Chief Scientific Officer,
Valo Therapeutics
Xi Zhao
Senior Principal Scientist,
AbbVie
All Speakers
Alastair Corbin
Principal Scientist,
Pathios Therapeutics
Alexandra Sevko
Director,
Prokarium
Amit Grover
Associate Principal Scientist,
AstraZeneca
Angelica Loskog
Chief Executive Officer,
Lokon Pharma AB
Benoit Van den Eynde
Professor,
Ludwig Institute for Cancer Research, Oxford University / VOLT
.jpg?length=600&name=acfa91cc-9563-4080-a43b-69834af66302-2-11764368speaker_photo-Christopher-Holland-1788-(3).jpg)
Chris Holland
Senior Manager,
Immunocore
Christine Rothe
Chief Development Officer,
iOmx Therapeutics
Cynthia Chauvin-Fleurence
Associate Principal Scientist,
AstraZeneca
Deepak Bhere
Assistant Professor,
University of South Carolina School of Medicine
Emiko DESVAUX
Principal Scientist, Translational Medicine,
Sanofi
Eric O'Neill
Professor of Cell & Molecular Biology,
Centre for Medicines Discovery
Ida Uddbäck
Senior Scientist,
Alligator Bioscience AB
Jens Vindahl Kringelum
Vice President,
Evaxion Biotech
Johan Pijnenborg
Chief Executive Officer,
GlycoTherapeutics B.V.
John Maher
Chief Scientific Officer,
Leucid Bio
.png?length=600&name=ea4e7755-5f7e-4ba0-a828-9ce9ab577c80-2-11764368speaker_photo-MicrosoftTeams-image-(1).png)
John Bridgeman
Research Director,
Instil Bio
Jon Moore
Chief Scientific Officer,
Epitopea Limited
Jonathan Kwok
Chief Executive Officer,
Infinitopes
Kenneth Crook
Head of Translational Medicine,
Engimmune Therapeutics
Kieran Whelton
Data Scientist,
AbbVie
Klaus Okkenhaug
Professor of Immunology,
University of Cambridge
Livija Deban
Chief Scientific Officer,
Prokarium
Maria Amann
Principal Scientist,
China Innovation Center of Roche
María Laura Garcia Bermejo
Scientific Director,
Ramon y Cajal Health Research Institute (IRYCIS)
Maria Stella Sasso
Senior Principal Scientist,
Akamis Bio Ltd
.jpg?length=600&name=f154810c-d37d-4dd2-885b-5c0906b9208b-2-11764368speaker_photo-Mark-Cragg-(7.5).jpg)
Mark Cragg
Professor of Experimental Cancer Biology,
University of Southampton
Martin Miller
Senior Director,
AstraZeneca
Massimiliano Mellone
Senior Research,
AstraZeneca
Natalia Venetz
Senior Scientist,
Molecular Partners AG
Nisit Khandelwal
Chief Technology Officer,
iOmx Therapeutics
Øystein Rekdal
Chief Executive Officer,
Lytix Biopharma
Pedro Correa de Sampaio
Chief Executive Officer,
Neobe
Phil Brailey
SSII,
Crescendo Biologics
Philip Arlen
Chief Executive Officer,
Precision Biologics
Philip Beer
Chief Scientific Officer,
Step Pharma
Pierre Dönnes
Vice President,
Strike Pharma
Rahul Roychoudhuri
Professor,
University of Cambridge
Raj Mehta
Chief Executive Officer,
Adendra Therapeutics Ltd
Rick Kamps
NGS Lab Manager,
University of Maastricht Translational Genomics
Robyn Broad
Principal Scientist,
Adaptimmune
Russell LaMontagne
Chief Executive Officer,
Boston Immune Technologies and Therapeutics, Inc.
Sarah-Kim Friedrich-Becker
Senior Principal Scientist,
Abalos Therapeutics GmbH
Simon Barry
Executive Director,
AstraZeneca
Sophia Karagiannis
Professor of Translational Cancer Immunology and Immunotherapy,
King's College London
Steve Thorne
Cso,
Kalivir
Sylwia Marshall
Vice President Translational Sciences,
InvoX Pharma
Thorsten Ross
Vice President,
CatalYm GmbH
Timo Van den Berg
Senior Director Immuno-Oncology,
Byondis
William Jackson
Senior Scientist,
Bioarchitech Ltd
Yi-Ru Yu
Senior Scientist,
Pilatusbio
Yong-Jie Lu
Professor in Molecular Oncology,
Queen Mary University of London